Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Ovarian Epithelial Carcinoma
Status:
Not yet recruiting
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
This study was a single-center, open-label, investigator-initiated clinical trial (IIT) to
observe and investigate the clinical safety and efficacy of SZ011 in the treatment of ovarian
epithelial carcinoma